Biomimetic Nanoparticles for the Treatment of Hematologic Malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biomimetic Nanoparticles for the Treatment of Hematologic Malignancies

Published:2021-02-08 Issue:4 Volume:1 Page:2000047
ISSN:2699-9307
Container-title:Advanced NanoBiomed Research
language:en
Short-container-title:Adv NanoBio Res

Author:

Powsner Emily H.¹,Harris Jenna C.²,Day Emily S.¹²³^ORCID

Affiliation:

1. Department of Biomedical Engineering University of Delaware 161 Colburn Lab Newark DE 19716 USA

2. Department of Materials Science and Engineering University of Delaware 127 The Green Newark DE 19716 USA

3. Center for Translational Cancer Research Helen F. Graham Cancer Center and Research Institute 4701 Ogletown Stanton Road Newark DE 19713 USA

Funder

National Science Foundation

University City Science Center

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anbr.202000047

Reference104 articles.

1. Epidemiology of hematological malignancies

2. Garcinol: Preclinical Perspective Underpinning Chemo- and Radiosensitization of Cancer

3. “Acute Myeloid Leukemia—Cancer Stat Facts ”https://seer.cancer.gov/statfacts/html/amyl.html(accessed: August 2020).

4. Prevalence, predictors, and outcomes of steroid-induced hyperglycemia in hospitalized patients with hematologic malignancies

5. Nivolumab in the Treatment of Hodgkin Lymphoma

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of BAFF targeting immunotherapy in B-cell neoplasm;International Journal of Clinical Oncology;2024-09-02

2. The clinical regimens and cell membrane camouflaged nanodrug delivery systems in hematologic malignancies treatment;Frontiers in Pharmacology;2024-04-16

3. Nanoparticle-Based Approaches for Treatment of Hematological Malignancies: a Comprehensive Review;AAPS PharmSciTech;2023-11-16

4. Supremacy of nanoparticles in the therapy of chronic myelogenous leukemia;ADMET and DMPK;2023-09-26

5. Targeted Lymphoma Therapy Using a Gold Nanoframework-Based Drug Delivery System;ACS Applied Materials & Interfaces;2023-01-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3